D. E. Shaw & Co., Inc. Denali Therapeutics Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.96 - $23.22 $1.29 Million - $2.01 Million	-86,544 Reduced 74.44%	29,721 $690,000
Q1 2024 May 15, 2024	BUY	$15.83 - $23.35 $1.84 Million - $2.71 Million	116,265 New	116,265 $2.39 Million
Q1 2023 May 15, 2023	SELL	$21.91 - $32.67 $1.97 Million - $2.94 Million	-90,091 Reduced 67.02%	44,336 $1.02 Million
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $3.53 Million - $4.56 Million	134,427 New	134,427 $3.74 Million
Q2 2022 Aug 15, 2022	BUY	$20.88 - $35.19 $1.67 Million - $2.81 Million	79,865 Added 1278.25%	86,113 $2.53 Million
Q1 2022 May 16, 2022	SELL	$29.0 - $47.27 $28,652 - $46,702	-988 Reduced 13.65%	6,248 $201,000
Q4 2021 Feb 14, 2022	SELL	$42.59 - $55.02 $1.63 Million - $2.1 Million	-38,177 Reduced 84.07%	7,236 $323,000
Q3 2021 Nov 15, 2021	SELL	$48.48 - $78.23 $1.85 Million - $2.99 Million	-38,172 Reduced 45.67%	45,413 $2.29 Million
Q2 2021 Aug 16, 2021	SELL	$50.3 - $78.44 $6.17 Million - $9.61 Million	-122,577 Reduced 59.46%	83,585 $6.56 Million
Q1 2021 May 17, 2021	BUY	$53.8 - $81.53 $6.82 Million - $10.3 Million	126,802 Added 159.78%	206,162 $11.8 Million
Q4 2020 Feb 16, 2021	SELL	$36.89 - $93.56 $2.42 Million - $6.14 Million	-65,658 Reduced 45.28%	79,360 $6.65 Million
Q3 2020 Nov 16, 2020	BUY	$23.13 - $38.84 $3.35 Million - $5.63 Million	145,018 New	145,018 $5.2 Million
Q3 2019 Nov 14, 2019	SELL	$15.32 - $21.92 $1.57 Million - $2.24 Million	-102,274 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.5 - $28.14 $1.89 Million - $2.88 Million	102,274 New	102,274 $2.12 Million

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

Baillie Gifford & CO

13.3M
Shares

$287 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.2M
Shares

$283 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

11.2M
Shares

$240 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.7M
Shares

$231 Million
0.06% of portfolio
Capital Research Global Investors Los Angeles, CA

7.91M
Shares

$170 Million
0.05% of portfolio

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account